Valuation: Coeptis Therapeutics

Market Cap 102M 88.28M 82.44M 75.63M 142M 9.71B 145M 967M 380M 4.87B 383M 375M 16.1B P/E 2024
-1.08x
P/E 2025 -5.06x
Enterprise Value 95.98M 83.02M 77.53M 71.12M 134M 9.13B 136M 910M 357M 4.58B 360M 353M 15.14B EV / Sales 2024
-
EV / Sales 2025 51.4x
Free-Float
-
Yield 2024 *
-
Yield 2025 -
1 day+2.54%
Current month-75.37%
6 months-67.05%
Current year-71.65%
Current year 3.83
Extreme 3.83
17.27
1 year 3.83
Extreme 3.83
21.41
3 years 2.31
Extreme 2.31
27.6
5 years 2.31
Extreme 2.31
428.4
10 years 2.31
Extreme 2.31
428.4

Financials

2024 2025
Net sales - 1.36M 1.18M 1.1M 1.01M 1.9M 130M 1.93M 12.92M 5.07M 65.02M 5.12M 5.01M 215M
Net income -9.81M -8.49M -7.93M -7.27M -13.68M -934M -13.9M -93.01M -36.5M -468M -36.85M -36.05M -1.55B -11.92M -10.31M -9.63M -8.83M -16.61M -1.13B -16.87M -113M -44.33M -568M -44.75M -43.77M -1.88B
Net Debt 866K 749K 700K 642K 1.21M 82.43M 1.23M 8.21M 3.22M 41.32M 3.25M 3.18M 137M -6.08M -5.26M -4.91M -4.51M -8.48M -579M -8.61M -57.64M -22.62M -290M -22.84M -22.34M -959M
Logo Coeptis Therapeutics
Coeptis Therapeutics Holdings, Inc. is a biopharmaceutical company developing cell therapy platforms for cancer, autoimmune, and infectious diseases. Its product portfolio is highlighted by assets licensed from Deverra Therapeutics, including an allogeneic cellular immunotherapy platform and DVX201, a clinical-stage, unmodified natural killer cell therapy technology. It is developing a universal, multi-antigen CAR technology licensed from the University of Pittsburgh (SNAP-CAR), and the GEAR cell therapy and companion diagnostic platforms in collaboration with VyGen-Bio and medical researchers at the Karolinska Institute. Its NexGenAI Affiliates Network platform offers AI-powered marketing software and advanced robotic process automation capabilities. Its Coeptis Technologies division is focused on diversifying and enhancing its growth potential. Its subsidiaries include Coeptis Therapeutics, Inc., Coeptis Pharmaceuticals, Inc., GEAR Therapeutics, Inc. and SNAP Biosciences, Inc.
Employees
5
Sector
-
Date Price Change Volume
26-08-07 US$4.040 +2.54% 331,202
26-08-06 US$3.940 -4.14% 286,111
26-08-05 US$4.110 -4.42% 764,464
26-08-04 US$4.300 -16.34% 755,255
26-08-03 US$5.140 +6.86% 309,390
  1. Stock Market
  2. Stocks
  3. COEP Stock